David T. Miyamoto MD PhD
Associate Professor of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
Join to View Full Profile
55 Fruit StBoston, MA 02114
Phone+1 617-726-5866
Fax+1 617-726-3603
Dr. Miyamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2026
ME State Medical License 2020 - 2021
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2014, 2016-2017
Publications & Presentations
PubMed
- Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy.David J Konieczkowski, Keisuke Otani, Zoe Guan, Michael R Drumm, Yukako Otani
NPJ Precision Oncology. 2025-12-01 - Bystander Effects in Osteoblasts and Osteoclasts: Comparison Between X- and Proton-Irradiation.Noriyuki Okonogi, Yukako S Otani, Keisuke Otani, Paola Divieti Pajevic, Yunhe Xie
International Journal of Particle Therapy. 2025-12-01 - Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy.Keyur D Shah, Beow Y Yeap, Hoyeon Lee, Zainab O Soetan, Maryam Moteabbed
JCO Clinical Cancer Informatics. 2025-03-01
Journal Articles
- A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerDavid T Miyamoto, Aditya Bardia, Lecia V Sequist, Laura M Spring, Daniel A Haber, Mark Kalinich, Clinical Cancer Research
Press Mentions
MRI-Guided SBRT Shows Sustained Benefits for Prostate CancerOctober 4th, 2024
New Discovery by Massachusetts General Hospital May Help Medical Laboratories Preserve Blood for DNA Analysis, Thus Allowing Isolation of CTCs up to 72 Hours After CollectionJune 27th, 2018
Henning Willers, MD and David Miyamoto, MD, PhD Receive $150,000 Grant from Aid for Cancer ResearchMay 21st, 2018
Grant Support
- Integration of circulating tumor cell and nuclear imaging biomarkers to assess LuPSMA response and resistance in advanced prostate cancer patientsMASSACHUSETTS GENERAL HOSPITAL2025–2030
- Blood-based monitoring of bladder-sparing trimodality therapy for muscle-invasive bladder cancerMASSACHUSETTS GENERAL HOSPITAL2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
